Choose a research collaboration or a corporate enquiry. Prepare a short, non-sensitive outline, then continue to the existing Hybrid contact page.
RESEARCH COLLABORATION
Discuss a research collaboration.
For institutions, researchers, clinicians and pharmaceutical or study teams shaping a bounded future workflow.
Describe the evidence gap and intended research purpose.
Name responsibilities and constraints, without sending source data.
A conversation is not study enrollment, dataset access or an active service engagement.
Suggested research outline
RESEARCH COLLABORATION ENQUIRY — HYBRID DISCOVERY
Organisation and your role:
Research question and intended value:
Resource category and responsible custodian (no samples):
Proposed collaborators and responsibilities:
Permitted purpose, location and retention constraints:
What success would demonstrate:
Please include no patient records, identifiers, medical images, confidential datasets, linkage keys or credentials.
For corporate partners, investor introductions, journalists and teams requesting public information or a presentation.
Identify the topic, audience and public materials involved.
Use the media library for the current corporate overview and brand assets.
This is a corporate conversation, not a patient or research-submission channel.
Suggested corporate outline
CORPORATE OR MEDIA ENQUIRY — HYBRID DISCOVERY
Organisation and your role:
Enquiry type (corporate discussion, press, interview or presentation):
Topic and intended audience:
Public material you are referring to:
Requested format and timing, if relevant:
Please include no confidential research material, patient information, credentials or investment account details.